NFKB1 and glioblastoma: In contrast to RelB/p52 complexes, the less understood RelB/p50 complexes are activated by the canonical pathway, limit inflammation in innate immune cells, control adaptive responses in astrocytes, are not easily removed from DNA, and provide long-lasting effects19,29,36, but they have not been shown to play any role in GBM.